| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a946395b559745e72bb08b1cedfb365 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90241 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2018-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9cb9ad438a8f03f94a11516ad4d14b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc629296fae0e5181dc670a43d453a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1da48d4655bb360e8914649a0895ca53 |
| publicationDate |
2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018234577-A1 |
| titleOfInvention |
IMMUNO-ONCOLOGY FOR THE TREATMENT OF CANCER |
| abstract |
The invention relates to a method for identifying a tumor associated antigen (TAA) in the context of prostate cancer. In addition, the invention relates to a method of identifying a TAA as a marker of the response of the prostate cancer vaccine. In particular, the invention relates to a method of identifying a prostate cancer patient and treating that patient by means of PROSTVAC therapy or vaccination with a prostate antigen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021028468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110687283-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110687283-A |
| priorityDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |